Tag Archives: PBM

Capital Rx Expands Transparency Model to Specialty and Mail Prescriptions

Capital Rx works to increase cost transparency and consistency for its clients by using the government-maintained National Average Drug Acquisition Cost database, which aims to provide accurate, upfront costs of drugs across pharmacies to health plans

Programs Covering the Cost of Gene Therapies Increase

Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers

Maxor Specialty Pharmacy Reorganizes

Maxor Specialty Pharmacy has a focus on pulmonary disease

SSM Health Repositioning as a Fully Integrated System

SSM Health has been moving from a combination of facilities and states to a fully integrated health system

OptumRx Integration of Diplomat to Add to Growing Specialty Drug Share

OptumRx has been aggressively growing its portfolio of pharmacy care services businesses

Will Diplomat Pharmacy Survive?

Diplomat found that competing successfully with large specialty pharmacies owned by Cigna/ESI, CVS Health/Caremark and UnitedHealth/OptumRx has been more difficult than projected

What’s Next for Diplomat Pharmacy After Poor Results in Q2 2019?

Diplomat’s core specialty pharmacy performance is being negatively impacted by increased competition